Our Values
Respecting healthy life
Creating & sharing knowledge
Committing to trust & quality
Founded by the leaders
in Lynch syndrome research
Lynsight has been on the forefront of Lynch syndrome research for over 10 years, driven by the mission to find a better way to help people prevent cancer. What started in the labs of the University of Helsinki in the 1990s will not stop until every potential Lynch syndrome case is tested every year.
Bringing preventative care to
more families
Every Lynch syndrome case that remains unclear is an entire family that could be missing out on life saving cancer preventative strategies. Lynsight is dedicated to making sure these families become known and cared for by testing for Lynch syndrome early.
ABOUT LYNCH
SYNDROME
Lynch syndrome is the main cause of hereditary cancers with a broad spectrum of tumors, the most prominent being colorectal and endometrial cancers. With an estimated 1 in 300 people of the world’s population being affected by Lynch syndrome, there are millions of people at a very increased risk for cancer.
The future of
Lynch syndrome testing
Lynsight’s purpose is to improve global health outcomes by providing reliable diagnostics for Lynch syndrome and promoting awareness about hereditary cancer risks. With a commitment to pushing the boundaries of scientific discovery, we’re leading the way toward a future where Lynch syndrome testing is not only more accessible but also more precise and impactful.